Updating results…
What is Vilazodone?
Vilazodone is a selective serotonin reuptake inhibitor/5-HT1A receptor partial agonist, antidepressant. It is used in the treatment of major depressive disorder.
Reported Purpose & Perceived Effectiveness
| Perceived Effectiveness | |||||||
|---|---|---|---|---|---|---|---|
| Purpose | # of patients | # of patients with evaluations | Major | Moderate | Slight | None | Can’t tell |
| Major Depressive Disorder | 21 | 11 |
|
|
|
|
|
| Depression with anxiety | 18 | 9 |
|
|
|
|
|
| Depressed mood | 15 | 7 |
|
|
|
|
|
| Fibromyalgia | 4 | 3 |
|
|
|||
| Generalized Anxiety Disorder | 4 | 2 |
|
|
|||
| Bipolar Disorder | 3 | 0 | |||||
See all 48 patients currently taking Vilazodone
Mouse over the table for more information
Reported Side Effects
Commonly reported side effects, conditions, and hospitalizations associated with Vilazodone
| Diarrhea | 5 | |
|---|---|---|
| Nausea | 3 | |
| Hospitalization | 3 | |
| Headaches | 2 | |
| Flatulence | 2 | |
| Abdominal bloating | 1 | |
| See all 29 reported side effects ▼ | ||
Reported Dosages
Reported Stop Reasons
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 9 |  |
|
| Did not seem to work | 7 | |
|
| Doctor's advice | 7 | |
|
| Expense | 1 | |
|
| Course of treatment ended | 1 | |
|
| Not indicated | 1 | |
Reported Duration See details about how long patients take this treatment ▼
Reported Adherence, Burden & Cost See details from patient evaluations ▼
Adherence
Taking treatment as prescribed
Adherence of Vilazodone
Always |
24 | 86% |
|
|---|---|---|---|
Usually |
1 | 4% |
|
Sometimes |
1 | 4% |
|
Never |
2 | 7% |
|
Burden
Difficulty being on treatment
Burden of Vilazodone
Very |
1 | 4% |
|
|---|---|---|---|
Somewhat |
0 | 0% |
|
A little |
6 | 21% |
|
Not at all |
21 | 75% |
|
Cost
Paid out of pocket
Cost of Vilazodone
$200+ |
0 | 0% |
|
|---|---|---|---|
$100-199 |
0 | 0% |
|
$50-99 |
6 | 27% |
|
$25-49 |
10 | 45% |
|
< $25 |
6 | 27% |
|
1 helpful mark
0 helpful marks